Good post. The last 2 occasions I’ve seen LC in Sydney she looked tired . And it’s easy to understand. Her workload must have been unbelievable over the last year. One only has to read the announcements and think for a moment about the work that went into each one. Just the effort to write up the announcements can be quite onerous. Complying with the ASX,FDA and Nasdaq rules is hard enough!
Less than 2 years ago IMU had 6 employees. Now they have added a host of new talent. All of these people needed to be sourced, interviewed, selected and brought onboard.
Ten trials underway. The logistics in that would be a Herculean effort. Imagine handing over the responsibilities to each of these new hires. What a learning curve they must be on. And who did all that work? LC is my best guess.
This company has literally exploded in size and scope! In a very short time period. Whilst the HC armchair experts with zero experience or knowledge of the work required ti get where we are , can luxuriate all day at their keyboards with nothing more on their plate than ti create criticism.
Whilst I appreciate every poster’s sensible and thoughtful post, I wonder how much they really know about commercialisation of technologies such as IMU is developing. Again IMU is really breaking new ground and exploring their options. Whilst PH has some success and experience executing deals and making exits, it’s not as if he is doing this regularly. That’s one reason they are recruiting US dealmakers.,These people are current and well networked. This takes an enormous amount of time and due diligence. Anybody who doubts this need only to look at the sporting press. This is no different to building a winning sports team.
Did PH and LC really have time to produce a slick NASDAQ style prospectus that would satisfy the HotCopper critics?.
IMJ has clearly stated their business strategies! Nothing has changed at all. PH has said several times that he would definitely consider acquisitions if the right assets were found at a great price. He also said they intend to partner , licence or sell assets at the right price. No things changed except they have bought a LATE STAGE program in Azer-cel that’s close to commercialisation, it comes with a ton of data. And relatively cheap and fast to get FDA breakthrough approval. The strategy hasn’t changed, they still want to license, partner and or sell. Going to
Market with one program is an added option. But the priority is to sell , license or partner. It’s a Brilliant move.
This is serendipitous. How they found CF33, then added CD19 and now added and Allogenic CarT . They have wrapped up the whole market.
Have the readers here even considered how much this is worth to BIG PHARMA! Or how desirable it would be to land this prized asset if BP need to stay competitive?
The complaints about valuations of projects and expectations of returns, being provided by IMU is all a bit premature at this stage. These programs are first in class. This is a whole new planning field. A universal
Vaccine against all cancers.
Maybe it would be well worth the effort to research the guidance released by Apple in 2007 when they released the first IPHONE.,or Microsoft when they released Windows.
Really it’s like putting hot air in a paper bag. Imagine the uproar that if IMU announced “ expected sales of US$100Bn per year”. Or worse “ Upon successful completion of Oncarlytic Trials we expect our technology will be worth US$500bn.”.
It’s my view that LC and PH have done an outstanding job to get IMU to where it is . Creating a Universal Vaccine against all cancers isn’t easy! If it was easy everyone would be doing it!
IMU Price at posting:
6.4¢ Sentiment: Buy Disclosure: Held
(20min delay)